ATAI Life Sciences N.V. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ATAI Life Sciences N.V. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2020 to 2023.
  • ATAI Life Sciences N.V. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • ATAI Life Sciences N.V. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$8.36M, a 140% decline from 2022.
  • ATAI Life Sciences N.V. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $20.8M, a 94.9% decline from 2021.
  • ATAI Life Sciences N.V. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $410M, a 263% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$8.36M -$29.1M -140% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $20.8M -$389M -94.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $410M +$297M +263% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $113M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.